Hepion Pharmaceuticals
HEPA
#10434
Rank
A$0.82 M
Marketcap
$0.76
Share price
-4.90%
Change (1 day)
-81.01%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2024 (TTM): -A$44.65 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$81.67 Million a decrease over its 2022 earnings that were of -A$74.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$44.65 Million-45.33%
2023 -A$81.67 Million9.74%
2022 -A$74.42 Million37.49%
2021 -A$54.13 Million61.27%
2020 -A$33.57 Million174.55%
2019 -A$12.23 Million-31.28%
2018 -A$17.8 Million
2016 -A$35.31 Million6.03%
2015 -A$33.3 Million265%
2014 -A$9.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion 375.25%๐Ÿ‡บ๐Ÿ‡ธ USA